Document Type
Editorial
Publication Title
Frontiers in Cellular and Infection Microbiology
Volume
13
PubMed ID
36968104
Publisher
Frontiers
School
Centre for Precision Health
Funders
National Natural Science Foundation of China (82222052, 32070710)
Abstract
Cancer is a devastating disease that remains a leading cause of death worldwide. According to recent statistics, cancer was responsible for 10 million deaths in 2020 alone (Ferlay et al., 2021). Of these cases, viral infections associated cancers have been found to contribute to a significant proportion, with chronic infections such as hepatitis B and C viruses (HBV and HCV), human papillomavirus (HPV), Epstein-Barr virus (EBV), and Human immunodeficiency virus (HIV) being particularly noteworthy. Inflammation and immune response are also closely linked to tumorigenesis, making it crucial to understand how viral infections and host immune response contribute to cancer development (Anand et al., 2008; White et al., 2014). To this end, a special Research Topic has been prepared to advance our knowledge in this field.
DOI
10.3389/fcimb.2023.1177032
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Comments
Li, X., An, L., Jin, Y., Gui, J., Lin, W., Wen, Z., ... & Chen, J. (2023). Editorial: Viral infection, tumor development and host immune response. Frontiers in Cellular and Infection Microbiology, 13, 293. https://doi.org/10.3389/fcimb.2023.1177032